Takeda Pharmaceutical Stock Price, News & Analysis (OTCMKTS:TKPYY)

Today's Range N/A
50-Day Range
$16.86
MA: $18.74
$21.22
52-Week Range N/A
Volume2.01 million shs
Average Volume5.90 million shs
Market Capitalization$28.03 billion
P/E Ratio12.11
Dividend Yield3.48%
Beta0.42
Takeda Pharmaceutical Company Limited engages in the research and development, manufacture, marketing, and sale of pharmaceutical products worldwide. The company operates in three segments: Prescription Drug, Consumer Healthcare, and Other. It offers prescription, OTC, and quasi-drugs; and reagents in various therapeutic areas, including oncology, gastroenterology, central nervous system (CNS), vaccines, and others. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TKPYY
CUSIPN/A
CIKN/A
Phone816-6204-2111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.99 billion
Book Value$11.62 per share

Profitability

Net Income$1.68 billion

Miscellaneous

EmployeesN/A
Outstanding Shares1,562,360,000
Market Cap$28.03 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive TKPYY News and Ratings via Email

Sign-up to receive the latest news and ratings for TKPYY and its competitors with MarketBeat's FREE daily newsletter.


Takeda Pharmaceutical (OTCMKTS:TKPYY) Frequently Asked Questions

What is Takeda Pharmaceutical's stock symbol?

Takeda Pharmaceutical trades on the OTCMKTS under the ticker symbol "TKPYY."

Has Takeda Pharmaceutical been receiving favorable news coverage?

News coverage about TKPYY stock has been trending negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Takeda Pharmaceutical earned a news impact score of -2.9 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Takeda Pharmaceutical.

Who are some of Takeda Pharmaceutical's key competitors?

What other stocks do shareholders of Takeda Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Takeda Pharmaceutical investors own include Proteostasis Therapeutics (PTI), Idera Pharmaceuticals (IDRA), Pfizer (PFE), Allena Pharmaceuticals (ALNA), Clearside Biomedical (CLSD), OrganiGram (OGI), Resonant (RESN), Syndax Pharmaceuticals (SNDX), Eli Lilly And Co (LLY) and BGC Partners (BGCP).

Who are Takeda Pharmaceutical's key executives?

Takeda Pharmaceutical's management team includes the folowing people:
  • Mr. Christophe Weber, Pres, CEO & Representative Director (Age 52)
  • Mr. Andrew S. Plump M.D., Ph.D., Chief Medical & Scientific Officer and Director
  • Dr. Seigo Izumo M.D., Chair of Management Board
  • Mr. Costa Saroukos, Chief Financial Officer
  • Mr. Haruhiko Hirate, Member of Management Board and Corp. Communications & Public Affairs Officer

How do I buy shares of Takeda Pharmaceutical?

Shares of TKPYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

How big of a company is Takeda Pharmaceutical?

Takeda Pharmaceutical has a market capitalization of $0.00 and generates $15.99 billion in revenue each year. View Additional Information About Takeda Pharmaceutical.

What is Takeda Pharmaceutical's official website?

The official website for Takeda Pharmaceutical is http://www.takeda.com/.

How can I contact Takeda Pharmaceutical?

Takeda Pharmaceutical's mailing address is 1-1 Doshomachi 4-chome Chuo-ku, Osaka M0, 540-8645. The company can be reached via phone at 816-6204-2111.


MarketBeat Community Rating for Takeda Pharmaceutical (OTCMKTS TKPYY)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  138 (Vote Outperform)
Underperform Votes:  119 (Vote Underperform)
Total Votes:  257
MarketBeat's community ratings are surveys of what our community members think about Takeda Pharmaceutical and other stocks. Vote "Outperform" if you believe TKPYY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TKPYY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/20/2019 by MarketBeat.com Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel